## Key Hypothesis
Bayesian uncertainty modeling with active sampling improves out-of-distribution reliability.

## Implementation Delta
- Round 3: Bayesian Active Discovery Loop integrated cross-agent feedback and updated evaluation controls.
- Added stronger intervention consistency tests on multi-omics and EHR alignment.

## Strengths
- Good calibration under scarce-label conditions
- Improved reviewer-facing evidence packaging in round 3.

## Weaknesses
- Sampling policy can under-explore rare temporal events
- Computational cost remains non-trivial in challenging cohorts.

## Transferable Insights
- Posterior shift alarms improve safe deployment decisions
- Structured peer summaries accelerate inter-worker learning without exposing private reports.

## Open Problems
- Need better priors for multi-hospital transfer
- Trade-off between robustness and runtime budget remains significant.

## Proposed Next Move
- Round 3 refinement for Bayesian Active Discovery Loop: integrate top peer suggestions, tighten verifier checks, and reduce false negatives.
- Prioritize hypotheses that jointly reduce FNR and calibration error.
